Skip to content

A Clinical Assessment of the Hemacopolymer Daily Disposable Limbal Ring Soft Contact Lens

A Clinical Assessment of the Hemacopolymer Daily Disposable Limbal Ring Soft Contact Lens

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01965262
Enrollment
30
Registered
2013-10-18
Start date
2014-04-30
Completion date
2014-10-31
Last updated
2017-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

This purpose of this study is to compare the clinical performance and subjective acceptance of two different daily disposable limbal ring lenses.

Detailed description

This is a subject-masked, dispensing study designed to evaluate the clinical performance and subjective acceptance when comparing two different daily disposable limbal ring lenses. Limbal ring lenses, which as well as correcting vision, have a colored ring which enhance the wearer's iris and are particularly popular in East Asian countries.

Interventions

DEVICEHema-copolymer Lens

contact lens

DEVICEetafilcon A Lens

contact lens

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Subjects will only be eligible for the study if: * They are 18 years of age and above. * They understand their rights as a research subject and are willing and able to sign a Statement of Informed Consent. * They are willing and able to follow the protocol. * They agree not to participate in other clinical research for the duration of this study. * They can attain at least 6/9 in each eye with the study lenses within the available power range. * They can be fitted with study lenses within the available power range. * The currently use soft contact lenses, or have done so within the last six months.

Exclusion criteria

Subjects will not be able to take part in the study if: * They have an ocular disorder which would normally contraindicate contact lens wear. * They have a systemic disorder which would normally contraindicate contact lens wear. * They are using any topical medication such as eye drops or ointment. * They have had cataract surgery. * They have had corneal refractive surgery. * They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus. * They are pregnant or lactating. * They have any ocular abnormality which would, in the opinion of the investigator, normally contraindicate contact lens wear. * They have any infectious disease which would normally contraindicate contact lens wear, or may, in the opinion of the investigator, pose a risk to study personnel; or any immunosuppressive disease (e.g. HIV), or a history of anaphylaxis or severe allergic reactions. * They have taken part in any other clinical trial or research, within two weeks prior to starting this study.

Design outcomes

Primary

MeasureTime frameDescription
Visual Acuity - Hema-copolymer and Etafilcon ABaselineVisual acuity measured by logMAR of hema-copolymer and etafilcon A lenses assessed at baseline.
Biomicroscopy - Hema-copolymer and Etafilcon A1 weekBiomicroscopy is analyzed for hema-copolymer and etafilcon A at 1 week. (Scale 0-4, 0=normal, 4=severe).
Lens Surface - Deposition - Hema-copolymer and Etafilcon ABaselineLens surface of deposition for hema-copolymer and etafilcon A pair of lenses assessed at baseline. (Each pair of lenses worn by the participant was assigned a single grade). Overall score measured by Grade 0-4; 0=absent, clean surface, 4= multiple deposits.
Lens Surface - Debris - Hema-copolymer and Etafilcon ABaselineLens surface of debris for hema-copolymer and etafilcon A pair of lenses assessed at baseline. (Each pair of lenses worn by the participant was assigned a single grade). Overall score measured by Grade 0-4; 0=no debris present, 4=debris present more than two thirds of area beneath lens.
Lens Surface - Wettability - Hema-copolymer and Etafilcon ABaselineLens surface of wettability for hema-copolymer and etafilcon A pair of lenses assessed at baseline. (Each pair of lenses worn by the participant was assigned a single grade). Overall score measured by Grade 0-4; 0=fully wetting lens surface, 4=presence of one or more non-wetting areas.
Lens Fit - Horizontal Centration - Hema-copolymer and Etafilcon ABaselineLens fit of horizontal centration for hema-copolymer and etafilcon A lenses assessed at baseline. Overall score measured by extremely nasal, slightly nasal, optimum, slightly temporal, extremely temporal
Lens Fit - Vertical Centration - Hema-copolymer and Etafilcon ABaselineLens fit of vertical centration for hema-copolymer and etafilcon A lenses assessed at baseline. Overall score measured by extremely inferior, slightly inferior, optimum, slightly superior, extremely superior
Lens Fit - Corneal Centration - Hema-copolymer and Etafilcon ABaselineLens fit of corneal centration for hema-copolymer and etafilcon A lenses assessed at baseline. Overall score measured by extremely inadequate, slightly inadequate, optimum, slightly excessive, extremely excessive
Lens Fit - Lens Movement - Hema-copolymer and Etafilcon ABaselineLens fit of lens movement for hema-copolymer and etafilcon A lenses assessed at baseline. Overall score measured by extremely inadequate, slightly inadequate, optimum, slightly excessive, extremely excessive
Comfort Preference (Subjective Assessment) - Hema-copolymer and Etafilcon ABaselineSubjective Assessment of comfort preference for hema-copolymer and etafilcon A assessed at baseline. Scale 0-100, 0=causes pain, 100= excellent.
Vision Preference (Subjective Assessment) - Hema-copolymer and Etafilcon ABaselineSubjective Assessment of vision preference for hema-copolymer and etafilcon A lenses assessed at baseline. Scale 0-100, 0=unacceptable, 100= excellent.
Peripheral Blur (Subjective Assessment) - Hema-copolymer and Etafilcon ABaselineSubjective Assessment of peripheral blur is assessed at baseline. Scale 0-100, 0=unacceptable, 100= excellent.
Ocular Redness (Subjective Assessment) - Hema-copolymer and Etafilcon A1 weekSubjective Assessment of ocular redness for hema-copolymer and etafilcon A lenses lenses assessed at 1 week. Scale 0-100, 0=extremely poor, 100= excellent.
Handling (Subjective Assessment) - Hema-copolymer and Etafilcon A1 weekSubjective Assessment of handling (ease of insertion and ease of removal) for hema-copolymer and etafilcon A lenses assessed at 1 week. Scale 0-100, 0=unmanageable, 100= excellent.
Attractiveness (Subjective Assessment) - Hema-copolymer and Etafilcon ABaselineSubjective Assessment of attractiveness for hema-copolymer and etafilcon A lenses assessed at baseline. Scale 0-100, 0=extremely poor, 100= excellent.
Overall Impression (Subjective Assessment) - Hema-copolymer and Etafilcon ABaselineSubjective assessment of the overall impression for hema-copolymer and etafilcon A lenses assessed at baseline. Scale 0-100, 0=extremely poor, 100= excellent.

Countries

United Kingdom

Participant flow

Recruitment details

Thirty subjects were dispensed lenses, and nineteen subjects successfully wore both study products.

Participants by arm

ArmCount
Overall Baseline Characteristics
Randomized to wear the Hema-copolymer lens pair or the etafilcon A lens pair for one week then cross over to the alternate pair Hema-copolymer Lens: Hema-copolymer lens pair or the Etafilcon A lens pair etafilcon A Lens: Hema-copolymer lens pair or the Etafilcon A lens pair
30
Total30

Withdrawals & dropouts

PeriodReasonFG000FG001
Second Intervention (7 Days)Discontinued01
Second Intervention (7 Days)Poor lens fit09
Second Intervention (7 Days)Poor visual acuity10

Baseline characteristics

CharacteristicOverall Baseline Characteristics
Age, Continuous29.2 years
Sex: Female, Male
Female
22 Participants
Sex: Female, Male
Male
8 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
1 / 190 / 19
serious
Total, serious adverse events
0 / 190 / 19

Outcome results

Primary

Attractiveness (Subjective Assessment) - Hema-copolymer and Etafilcon A

Subjective Assessment of attractiveness for hema-copolymer and etafilcon A lenses assessed at 1 week. Scale 0-100, 0=extremely poor, 100= excellent.

Time frame: 1 week

Population: 11 subjects discontinued the study.

ArmMeasureValue (MEAN)Dispersion
Hema-copolymer LensAttractiveness (Subjective Assessment) - Hema-copolymer and Etafilcon A66.7 units on a scaleStandard Deviation 20
Etafilcon A LensAttractiveness (Subjective Assessment) - Hema-copolymer and Etafilcon A68.0 units on a scaleStandard Deviation 20.2
Primary

Attractiveness (Subjective Assessment) - Hema-copolymer and Etafilcon A

Subjective Assessment of attractiveness for hema-copolymer and etafilcon A lenses assessed at baseline. Scale 0-100, 0=extremely poor, 100= excellent.

Time frame: Baseline

Population: 8 subjects discontinued the study.

ArmMeasureValue (MEAN)Dispersion
Hema-copolymer LensAttractiveness (Subjective Assessment) - Hema-copolymer and Etafilcon A66.9 units on a scaleStandard Deviation 16.5
Etafilcon A LensAttractiveness (Subjective Assessment) - Hema-copolymer and Etafilcon A67.4 units on a scaleStandard Deviation 16.7
Primary

Biomicroscopy - Hema-copolymer and Etafilcon A

Biomicroscopy is analyzed for hema-copolymer and etafilcon A at 1 week. (Scale 0-4, 0=normal, 4=severe).

Time frame: 1 week

Population: 11 subjects discontinued the study.

ArmMeasureGroupValue (MEAN)Dispersion
Hema-copolymer LensBiomicroscopy - Hema-copolymer and Etafilcon AConjunctival hyperaemia0.96 units on a scaleStandard Deviation 0.18
Hema-copolymer LensBiomicroscopy - Hema-copolymer and Etafilcon ACorneal vascularisation0.10 units on a scaleStandard Deviation 0.22
Hema-copolymer LensBiomicroscopy - Hema-copolymer and Etafilcon ACorenal Staining0.26 units on a scaleStandard Deviation 0.41
Hema-copolymer LensBiomicroscopy - Hema-copolymer and Etafilcon ALimbal hyperameia0.86 units on a scaleStandard Deviation 0.27
Hema-copolymer LensBiomicroscopy - Hema-copolymer and Etafilcon AConjunctival Staining0.37 units on a scaleStandard Deviation 0.28
Hema-copolymer LensBiomicroscopy - Hema-copolymer and Etafilcon AMicrocysts0.00 units on a scaleStandard Deviation 0
Hema-copolymer LensBiomicroscopy - Hema-copolymer and Etafilcon APapillary Conjunctivitis0.87 units on a scaleStandard Deviation 0.35
Hema-copolymer LensBiomicroscopy - Hema-copolymer and Etafilcon AOedema0.00 units on a scaleStandard Deviation 0
Etafilcon A LensBiomicroscopy - Hema-copolymer and Etafilcon APapillary Conjunctivitis0.84 units on a scaleStandard Deviation 0.37
Etafilcon A LensBiomicroscopy - Hema-copolymer and Etafilcon AConjunctival hyperaemia0.96 units on a scaleStandard Deviation 0.19
Etafilcon A LensBiomicroscopy - Hema-copolymer and Etafilcon ALimbal hyperameia0.79 units on a scaleStandard Deviation 0.25
Etafilcon A LensBiomicroscopy - Hema-copolymer and Etafilcon ACorneal vascularisation0.11 units on a scaleStandard Deviation 0.26
Etafilcon A LensBiomicroscopy - Hema-copolymer and Etafilcon AMicrocysts0.00 units on a scaleStandard Deviation 0
Etafilcon A LensBiomicroscopy - Hema-copolymer and Etafilcon AOedema0.00 units on a scaleStandard Deviation 0
Etafilcon A LensBiomicroscopy - Hema-copolymer and Etafilcon ACorenal Staining0.44 units on a scaleStandard Deviation 0.55
Etafilcon A LensBiomicroscopy - Hema-copolymer and Etafilcon AConjunctival Staining0.33 units on a scaleStandard Deviation 0.34
Primary

Comfort Preference (Subjective Assessment) - Hema-copolymer and Etafilcon A

Subjective Assessment of comfort preference for hema-copolymer and etafilcon A assessed at baseline. Scale 0-100, 0=causes pain, 100= excellent.

Time frame: Baseline

Population: 7 subjects discontinued the study.

ArmMeasureValue (MEAN)Dispersion
Hema-copolymer LensComfort Preference (Subjective Assessment) - Hema-copolymer and Etafilcon A82.2 units on a scaleStandard Deviation 13.6
Etafilcon A LensComfort Preference (Subjective Assessment) - Hema-copolymer and Etafilcon A84.5 units on a scaleStandard Deviation 15.3
Primary

Comfort Preference (Subjective Assessment) - Hema-copolymer and Etafilcon A

Subjective Assessment of comfort preference after insertion and before removal for hema-copolymer and etafilcon A lenses is assessed at 1 week. Scale 0-100, 0=causes pain, 100= excellent.

Time frame: 1 week

Population: 11 subjects discontinued the study.

ArmMeasureGroupValue (MEAN)Dispersion
Hema-copolymer LensComfort Preference (Subjective Assessment) - Hema-copolymer and Etafilcon AComfort after insertion80.8 units on a scaleStandard Deviation 17
Hema-copolymer LensComfort Preference (Subjective Assessment) - Hema-copolymer and Etafilcon AComfort before removal69.1 units on a scaleStandard Deviation 19.2
Hema-copolymer LensComfort Preference (Subjective Assessment) - Hema-copolymer and Etafilcon AOverall comfort75.8 units on a scaleStandard Deviation 16.5
Etafilcon A LensComfort Preference (Subjective Assessment) - Hema-copolymer and Etafilcon AComfort after insertion76.0 units on a scaleStandard Deviation 16.1
Etafilcon A LensComfort Preference (Subjective Assessment) - Hema-copolymer and Etafilcon AComfort before removal66.6 units on a scaleStandard Deviation 19.5
Etafilcon A LensComfort Preference (Subjective Assessment) - Hema-copolymer and Etafilcon AOverall comfort69.5 units on a scaleStandard Deviation 20.8
Primary

Handling (Subjective Assessment) - Hema-copolymer and Etafilcon A

Subjective Assessment of handling (ease of insertion and ease of removal) for hema-copolymer and etafilcon A lenses assessed at 1 week. Scale 0-100, 0=unmanageable, 100= excellent.

Time frame: 1 week

Population: 11 subjects discontinued the study.

ArmMeasureGroupValue (MEAN)Dispersion
Hema-copolymer LensHandling (Subjective Assessment) - Hema-copolymer and Etafilcon AEase of removal95.2 units on a scaleStandard Deviation 8.1
Hema-copolymer LensHandling (Subjective Assessment) - Hema-copolymer and Etafilcon AEase of insertion92.0 units on a scaleStandard Deviation 10.3
Etafilcon A LensHandling (Subjective Assessment) - Hema-copolymer and Etafilcon AEase of insertion77.5 units on a scaleStandard Deviation 18.2
Etafilcon A LensHandling (Subjective Assessment) - Hema-copolymer and Etafilcon AEase of removal90.5 units on a scaleStandard Deviation 18.3
Primary

Lens Fit - Corneal Centration - Hema-copolymer and Etafilcon A

Lens fit of corneal centration for hema-copolymer and etafilcon A lenses assessed at 1 week. Overall score measured by extremely inadequate, slightly inadequate, optimum, slightly excessive, extremely excessive

Time frame: 1 week

Population: 11 subjects discontinued the study.

ArmMeasureGroupValue (NUMBER)
Hema-copolymer LensLens Fit - Corneal Centration - Hema-copolymer and Etafilcon AExtremely Inadequate0 Eyes
Hema-copolymer LensLens Fit - Corneal Centration - Hema-copolymer and Etafilcon AOptimum53 Eyes
Hema-copolymer LensLens Fit - Corneal Centration - Hema-copolymer and Etafilcon AExtremely Excessive0 Eyes
Hema-copolymer LensLens Fit - Corneal Centration - Hema-copolymer and Etafilcon ASlightly Excessive2 Eyes
Hema-copolymer LensLens Fit - Corneal Centration - Hema-copolymer and Etafilcon ASlightly Inadequate3 Eyes
Etafilcon A LensLens Fit - Corneal Centration - Hema-copolymer and Etafilcon AExtremely Excessive0 Eyes
Etafilcon A LensLens Fit - Corneal Centration - Hema-copolymer and Etafilcon AExtremely Inadequate0 Eyes
Etafilcon A LensLens Fit - Corneal Centration - Hema-copolymer and Etafilcon ASlightly Inadequate0 Eyes
Etafilcon A LensLens Fit - Corneal Centration - Hema-copolymer and Etafilcon AOptimum40 Eyes
Etafilcon A LensLens Fit - Corneal Centration - Hema-copolymer and Etafilcon ASlightly Excessive0 Eyes
Primary

Lens Fit - Corneal Centration - Hema-copolymer and Etafilcon A

Lens fit of corneal centration for hema-copolymer and etafilcon A lenses assessed at baseline. Overall score measured by extremely inadequate, slightly inadequate, optimum, slightly excessive, extremely excessive

Time frame: Baseline

Population: All 30 subjects were dispensed lenses, and lens fit of corneal centration measurements were obtained at baseline.

ArmMeasureGroupValue (NUMBER)
Hema-copolymer LensLens Fit - Corneal Centration - Hema-copolymer and Etafilcon ASlightly Inadequate1 Eyes
Hema-copolymer LensLens Fit - Corneal Centration - Hema-copolymer and Etafilcon ASlightly Excessive2 Eyes
Hema-copolymer LensLens Fit - Corneal Centration - Hema-copolymer and Etafilcon AExtremely Inadequate0 Eyes
Hema-copolymer LensLens Fit - Corneal Centration - Hema-copolymer and Etafilcon AExtremely Excessive0 Eyes
Hema-copolymer LensLens Fit - Corneal Centration - Hema-copolymer and Etafilcon AOptimum57 Eyes
Etafilcon A LensLens Fit - Corneal Centration - Hema-copolymer and Etafilcon AExtremely Excessive0 Eyes
Etafilcon A LensLens Fit - Corneal Centration - Hema-copolymer and Etafilcon AOptimum46 Eyes
Etafilcon A LensLens Fit - Corneal Centration - Hema-copolymer and Etafilcon AExtremely Inadequate6 Eyes
Etafilcon A LensLens Fit - Corneal Centration - Hema-copolymer and Etafilcon ASlightly Excessive0 Eyes
Etafilcon A LensLens Fit - Corneal Centration - Hema-copolymer and Etafilcon ASlightly Inadequate8 Eyes
Primary

Lens Fit - Horizontal Centration - Hema-copolymer and Etafilcon A

Lens fit of horizontal centration for hema-copolymer and etafilcon A lenses assessed at 1 week. Overall score measured by extremely nasal, slightly nasal, optimum, slightly temporal, extremely temporal

Time frame: 1 week

Population: 11 subjects discontinued the study.

ArmMeasureGroupValue (NUMBER)
Hema-copolymer LensLens Fit - Horizontal Centration - Hema-copolymer and Etafilcon ASlightly Nasal2 Eyes
Hema-copolymer LensLens Fit - Horizontal Centration - Hema-copolymer and Etafilcon ASlightly Temporal45 Eyes
Hema-copolymer LensLens Fit - Horizontal Centration - Hema-copolymer and Etafilcon AExtremely Nasal0 Eyes
Hema-copolymer LensLens Fit - Horizontal Centration - Hema-copolymer and Etafilcon AExtremely Temporal0 Eyes
Hema-copolymer LensLens Fit - Horizontal Centration - Hema-copolymer and Etafilcon AOptimum11 Eyes
Etafilcon A LensLens Fit - Horizontal Centration - Hema-copolymer and Etafilcon AExtremely Temporal0 Eyes
Etafilcon A LensLens Fit - Horizontal Centration - Hema-copolymer and Etafilcon AOptimum13 Eyes
Etafilcon A LensLens Fit - Horizontal Centration - Hema-copolymer and Etafilcon AExtremely Nasal0 Eyes
Etafilcon A LensLens Fit - Horizontal Centration - Hema-copolymer and Etafilcon ASlightly Temporal27 Eyes
Etafilcon A LensLens Fit - Horizontal Centration - Hema-copolymer and Etafilcon ASlightly Nasal0 Eyes
Primary

Lens Fit - Horizontal Centration - Hema-copolymer and Etafilcon A

Lens fit of horizontal centration for hema-copolymer and etafilcon A lenses assessed at baseline. Overall score measured by extremely nasal, slightly nasal, optimum, slightly temporal, extremely temporal

Time frame: Baseline

Population: All 30 subjects were dispensed lenses, and lens fit of horizontal centration measurements were obtained at baseline.

ArmMeasureGroupValue (NUMBER)
Hema-copolymer LensLens Fit - Horizontal Centration - Hema-copolymer and Etafilcon ASlightly Nasal1 Eyes
Hema-copolymer LensLens Fit - Horizontal Centration - Hema-copolymer and Etafilcon ASlightly Temporal38 Eyes
Hema-copolymer LensLens Fit - Horizontal Centration - Hema-copolymer and Etafilcon AOptimum21 Eyes
Hema-copolymer LensLens Fit - Horizontal Centration - Hema-copolymer and Etafilcon AExtremely Temporal0 Eyes
Hema-copolymer LensLens Fit - Horizontal Centration - Hema-copolymer and Etafilcon AExtremely Nasal0 Eyes
Etafilcon A LensLens Fit - Horizontal Centration - Hema-copolymer and Etafilcon AExtremely Temporal0 Eyes
Etafilcon A LensLens Fit - Horizontal Centration - Hema-copolymer and Etafilcon AExtremely Nasal0 Eyes
Etafilcon A LensLens Fit - Horizontal Centration - Hema-copolymer and Etafilcon ASlightly Nasal1 Eyes
Etafilcon A LensLens Fit - Horizontal Centration - Hema-copolymer and Etafilcon AOptimum19 Eyes
Etafilcon A LensLens Fit - Horizontal Centration - Hema-copolymer and Etafilcon ASlightly Temporal40 Eyes
Primary

Lens Fit - Lens Movement - Hema-copolymer and Etafilcon A

Lens fit of lens movement for hema-copolymer and etafilcon A lenses assessed at 1 week. Overall score measured by extremely inadequate, slightly inadequate, optimum, slightly excessive, extremely excessive

Time frame: 1 week

Population: 11 subjects discontinued the study.

ArmMeasureGroupValue (NUMBER)
Hema-copolymer LensLens Fit - Lens Movement - Hema-copolymer and Etafilcon AExtremely Excessive0 Eyes
Hema-copolymer LensLens Fit - Lens Movement - Hema-copolymer and Etafilcon ASlightly Inadequate5 Eyes
Hema-copolymer LensLens Fit - Lens Movement - Hema-copolymer and Etafilcon AOptimum33 Eyes
Hema-copolymer LensLens Fit - Lens Movement - Hema-copolymer and Etafilcon ASlightly Excessive20 Eyes
Hema-copolymer LensLens Fit - Lens Movement - Hema-copolymer and Etafilcon AExtremely Inadequate0 Eyes
Etafilcon A LensLens Fit - Lens Movement - Hema-copolymer and Etafilcon ASlightly Excessive8 Eyes
Etafilcon A LensLens Fit - Lens Movement - Hema-copolymer and Etafilcon AExtremely Excessive2 Eyes
Etafilcon A LensLens Fit - Lens Movement - Hema-copolymer and Etafilcon ASlightly Inadequate2 Eyes
Etafilcon A LensLens Fit - Lens Movement - Hema-copolymer and Etafilcon AExtremely Inadequate0 Eyes
Etafilcon A LensLens Fit - Lens Movement - Hema-copolymer and Etafilcon AOptimum28 Eyes
Primary

Lens Fit - Lens Movement - Hema-copolymer and Etafilcon A

Lens fit of lens movement for hema-copolymer and etafilcon A lenses assessed at baseline. Overall score measured by extremely inadequate, slightly inadequate, optimum, slightly excessive, extremely excessive

Time frame: Baseline

Population: All 30 subjects were dispensed lenses, and lens movement measurements were obtained at baseline.

ArmMeasureGroupValue (NUMBER)
Hema-copolymer LensLens Fit - Lens Movement - Hema-copolymer and Etafilcon AExtremely Excessive0 Eyes
Hema-copolymer LensLens Fit - Lens Movement - Hema-copolymer and Etafilcon AExtremely Inadequate0 Eyes
Hema-copolymer LensLens Fit - Lens Movement - Hema-copolymer and Etafilcon ASlightly Inadequate7 Eyes
Hema-copolymer LensLens Fit - Lens Movement - Hema-copolymer and Etafilcon AOptimum41 Eyes
Hema-copolymer LensLens Fit - Lens Movement - Hema-copolymer and Etafilcon ASlightly Excessive12 Eyes
Etafilcon A LensLens Fit - Lens Movement - Hema-copolymer and Etafilcon ASlightly Excessive16 Eyes
Etafilcon A LensLens Fit - Lens Movement - Hema-copolymer and Etafilcon AOptimum35 Eyes
Etafilcon A LensLens Fit - Lens Movement - Hema-copolymer and Etafilcon AExtremely Inadequate0 Eyes
Etafilcon A LensLens Fit - Lens Movement - Hema-copolymer and Etafilcon AExtremely Excessive9 Eyes
Etafilcon A LensLens Fit - Lens Movement - Hema-copolymer and Etafilcon ASlightly Inadequate0 Eyes
Primary

Lens Fit - Vertical Centration - Hema-copolymer and Etafilcon A

Lens fit of vertical centration for hema-copolymer and etafilcon A lenses assessed at 1 week. Overall score measured by extremely inferior, slightly inferior, optimum, slightly superior, extremely superior

Time frame: 1 week

Population: 11 subjects discontinued the study.

ArmMeasureGroupValue (NUMBER)
Hema-copolymer LensLens Fit - Vertical Centration - Hema-copolymer and Etafilcon ASlightly Inferior35 Eyes
Hema-copolymer LensLens Fit - Vertical Centration - Hema-copolymer and Etafilcon ASlightly Superior7 Eyes
Hema-copolymer LensLens Fit - Vertical Centration - Hema-copolymer and Etafilcon AOptimum16 Eyes
Hema-copolymer LensLens Fit - Vertical Centration - Hema-copolymer and Etafilcon AExtremely Superior0 Eyes
Hema-copolymer LensLens Fit - Vertical Centration - Hema-copolymer and Etafilcon AExtremely Inferior0 Eyes
Etafilcon A LensLens Fit - Vertical Centration - Hema-copolymer and Etafilcon AExtremely Superior0 Eyes
Etafilcon A LensLens Fit - Vertical Centration - Hema-copolymer and Etafilcon AExtremely Inferior0 Eyes
Etafilcon A LensLens Fit - Vertical Centration - Hema-copolymer and Etafilcon ASlightly Inferior11 Eyes
Etafilcon A LensLens Fit - Vertical Centration - Hema-copolymer and Etafilcon AOptimum17 Eyes
Etafilcon A LensLens Fit - Vertical Centration - Hema-copolymer and Etafilcon ASlightly Superior12 Eyes
Primary

Lens Fit - Vertical Centration - Hema-copolymer and Etafilcon A

Lens fit of vertical centration for hema-copolymer and etafilcon A lenses assessed at baseline. Overall score measured by extremely inferior, slightly inferior, optimum, slightly superior, extremely superior

Time frame: Baseline

Population: All 30 subjects were dispensed lenses, and lens fit of vertical centration measurements were obtained at baseline.

ArmMeasureGroupValue (NUMBER)
Hema-copolymer LensLens Fit - Vertical Centration - Hema-copolymer and Etafilcon AExtremely Inferior0 Eyes
Hema-copolymer LensLens Fit - Vertical Centration - Hema-copolymer and Etafilcon ASlightly Superior10 Eyes
Hema-copolymer LensLens Fit - Vertical Centration - Hema-copolymer and Etafilcon AOptimum28 Eyes
Hema-copolymer LensLens Fit - Vertical Centration - Hema-copolymer and Etafilcon AExtremely Superior0 Eyes
Hema-copolymer LensLens Fit - Vertical Centration - Hema-copolymer and Etafilcon ASlightly Inferior22 Eyes
Etafilcon A LensLens Fit - Vertical Centration - Hema-copolymer and Etafilcon AExtremely Superior0 Eyes
Etafilcon A LensLens Fit - Vertical Centration - Hema-copolymer and Etafilcon AExtremely Inferior2 Eyes
Etafilcon A LensLens Fit - Vertical Centration - Hema-copolymer and Etafilcon ASlightly Inferior24 Eyes
Etafilcon A LensLens Fit - Vertical Centration - Hema-copolymer and Etafilcon AOptimum19 Eyes
Etafilcon A LensLens Fit - Vertical Centration - Hema-copolymer and Etafilcon ASlightly Superior15 Eyes
Primary

Lens Surface - Debris - Hema-copolymer and Etafilcon A

Lens surface of debris for hema-copolymer and etafilcon A pair of lenses assessed at 1 week. (Each pair of lenses worn by the participant was assigned a single grade). Overall score measured by Grade 0-4; 0=no debris present, 4=debris present more than two thirds of area beneath lens.

Time frame: 1 week

Population: 11 subjects discontinued the study.

ArmMeasureGroupValue (NUMBER)
Hema-copolymer LensLens Surface - Debris - Hema-copolymer and Etafilcon AGrade 10 participants
Hema-copolymer LensLens Surface - Debris - Hema-copolymer and Etafilcon AGrade 30 participants
Hema-copolymer LensLens Surface - Debris - Hema-copolymer and Etafilcon AGrade 20 participants
Hema-copolymer LensLens Surface - Debris - Hema-copolymer and Etafilcon AGrade 40 participants
Hema-copolymer LensLens Surface - Debris - Hema-copolymer and Etafilcon AGrade 029 participants
Etafilcon A LensLens Surface - Debris - Hema-copolymer and Etafilcon AGrade 40 participants
Etafilcon A LensLens Surface - Debris - Hema-copolymer and Etafilcon AGrade 018 participants
Etafilcon A LensLens Surface - Debris - Hema-copolymer and Etafilcon AGrade 12 participants
Etafilcon A LensLens Surface - Debris - Hema-copolymer and Etafilcon AGrade 20 participants
Etafilcon A LensLens Surface - Debris - Hema-copolymer and Etafilcon AGrade 30 participants
Primary

Lens Surface - Debris - Hema-copolymer and Etafilcon A

Lens surface of debris for hema-copolymer and etafilcon A pair of lenses assessed at baseline. (Each pair of lenses worn by the participant was assigned a single grade). Overall score measured by Grade 0-4; 0=no debris present, 4=debris present more than two thirds of area beneath lens.

Time frame: Baseline

Population: All 30 subjects were dispensed lenses, and lens surface of debris measurements were obtained at baseline.

ArmMeasureGroupValue (NUMBER)
Hema-copolymer LensLens Surface - Debris - Hema-copolymer and Etafilcon AGrade 11 participants
Hema-copolymer LensLens Surface - Debris - Hema-copolymer and Etafilcon AGrade 30 participants
Hema-copolymer LensLens Surface - Debris - Hema-copolymer and Etafilcon AGrade 21 participants
Hema-copolymer LensLens Surface - Debris - Hema-copolymer and Etafilcon AGrade 40 participants
Hema-copolymer LensLens Surface - Debris - Hema-copolymer and Etafilcon AGrade 028 participants
Etafilcon A LensLens Surface - Debris - Hema-copolymer and Etafilcon AGrade 40 participants
Etafilcon A LensLens Surface - Debris - Hema-copolymer and Etafilcon AGrade 027 participants
Etafilcon A LensLens Surface - Debris - Hema-copolymer and Etafilcon AGrade 13 participants
Etafilcon A LensLens Surface - Debris - Hema-copolymer and Etafilcon AGrade 20 participants
Etafilcon A LensLens Surface - Debris - Hema-copolymer and Etafilcon AGrade 30 participants
Primary

Lens Surface - Deposition - Hema-copolymer and Etafilcon A

Lens surface of deposition for hema-copolymer and etafilcon A pair of lenses assessed at baseline. (Each pair of lenses worn by the participant was assigned a single grade). Overall score measured by Grade 0-4; 0=absent, clean surface, 4= multiple deposits.

Time frame: Baseline

Population: All 30 subjects were dispensed lenses, and lens surface of deposition measurements were obtained at baseline.

ArmMeasureGroupValue (NUMBER)
Hema-copolymer LensLens Surface - Deposition - Hema-copolymer and Etafilcon AGrade 30 participants
Hema-copolymer LensLens Surface - Deposition - Hema-copolymer and Etafilcon AGrade 11 participants
Hema-copolymer LensLens Surface - Deposition - Hema-copolymer and Etafilcon AGrade 029 participants
Hema-copolymer LensLens Surface - Deposition - Hema-copolymer and Etafilcon AGrade 40 participants
Hema-copolymer LensLens Surface - Deposition - Hema-copolymer and Etafilcon AGrade 20 participants
Etafilcon A LensLens Surface - Deposition - Hema-copolymer and Etafilcon AGrade 40 participants
Etafilcon A LensLens Surface - Deposition - Hema-copolymer and Etafilcon AGrade 20 participants
Etafilcon A LensLens Surface - Deposition - Hema-copolymer and Etafilcon AGrade 30 participants
Etafilcon A LensLens Surface - Deposition - Hema-copolymer and Etafilcon AGrade 030 participants
Etafilcon A LensLens Surface - Deposition - Hema-copolymer and Etafilcon AGrade 10 participants
Primary

Lens Surface - Deposition - Hema-copolymer and Etafilcon A

Lens surface of deposition for hema-copolymer and etafilcon A pair of lenses assessed at 1 week. (Each pair of lenses worn by the participant was assigned a single grade). Overall score measured by Grade 0-4; 0=absent, clean surface, 4= multiple deposits.

Time frame: 1 week

Population: 11 subjects discontinued the study.

ArmMeasureGroupValue (NUMBER)
Hema-copolymer LensLens Surface - Deposition - Hema-copolymer and Etafilcon AGrade 13 participants
Hema-copolymer LensLens Surface - Deposition - Hema-copolymer and Etafilcon AGrade 30 participants
Hema-copolymer LensLens Surface - Deposition - Hema-copolymer and Etafilcon AGrade 20 participants
Hema-copolymer LensLens Surface - Deposition - Hema-copolymer and Etafilcon AGrade 40 participants
Hema-copolymer LensLens Surface - Deposition - Hema-copolymer and Etafilcon AGrade 026 participants
Etafilcon A LensLens Surface - Deposition - Hema-copolymer and Etafilcon AGrade 40 participants
Etafilcon A LensLens Surface - Deposition - Hema-copolymer and Etafilcon AGrade 014 participants
Etafilcon A LensLens Surface - Deposition - Hema-copolymer and Etafilcon AGrade 16 participants
Etafilcon A LensLens Surface - Deposition - Hema-copolymer and Etafilcon AGrade 20 participants
Etafilcon A LensLens Surface - Deposition - Hema-copolymer and Etafilcon AGrade 30 participants
Primary

Lens Surface - Wettability - Hema-copolymer and Etafilcon A

Lens surface of wettability for hema-copolymer and etafilcon A pair lenses assessed at 1 week. (Each pair of lenses worn by the participant was assigned a single grade). Overall score measured by Grade 0-4; 0=fully wetting lens surface, 4=presence of one or more non-wetting areas.

Time frame: 1 week

Population: 11 subjects discontinued the study.

ArmMeasureGroupValue (NUMBER)
Hema-copolymer LensLens Surface - Wettability - Hema-copolymer and Etafilcon AGrade 16 participants
Hema-copolymer LensLens Surface - Wettability - Hema-copolymer and Etafilcon AGrade 30 participants
Hema-copolymer LensLens Surface - Wettability - Hema-copolymer and Etafilcon AGrade 24 participants
Hema-copolymer LensLens Surface - Wettability - Hema-copolymer and Etafilcon AGrade 40 participants
Hema-copolymer LensLens Surface - Wettability - Hema-copolymer and Etafilcon AGrade 019 participants
Etafilcon A LensLens Surface - Wettability - Hema-copolymer and Etafilcon AGrade 40 participants
Etafilcon A LensLens Surface - Wettability - Hema-copolymer and Etafilcon AGrade 013 participants
Etafilcon A LensLens Surface - Wettability - Hema-copolymer and Etafilcon AGrade 16 participants
Etafilcon A LensLens Surface - Wettability - Hema-copolymer and Etafilcon AGrade 21 participants
Etafilcon A LensLens Surface - Wettability - Hema-copolymer and Etafilcon AGrade 30 participants
Primary

Lens Surface - Wettability - Hema-copolymer and Etafilcon A

Lens surface of wettability for hema-copolymer and etafilcon A pair of lenses assessed at baseline. (Each pair of lenses worn by the participant was assigned a single grade). Overall score measured by Grade 0-4; 0=fully wetting lens surface, 4=presence of one or more non-wetting areas.

Time frame: Baseline

Population: All 30 subjects were dispensed lenses, and lens surface of wettability measurements were obtained at baseline.

ArmMeasureGroupValue (NUMBER)
Hema-copolymer LensLens Surface - Wettability - Hema-copolymer and Etafilcon AGrade 12 participants
Hema-copolymer LensLens Surface - Wettability - Hema-copolymer and Etafilcon AGrade 30 participants
Hema-copolymer LensLens Surface - Wettability - Hema-copolymer and Etafilcon AGrade 21 participants
Hema-copolymer LensLens Surface - Wettability - Hema-copolymer and Etafilcon AGrade 40 participants
Hema-copolymer LensLens Surface - Wettability - Hema-copolymer and Etafilcon AGrade 027 participants
Etafilcon A LensLens Surface - Wettability - Hema-copolymer and Etafilcon AGrade 40 participants
Etafilcon A LensLens Surface - Wettability - Hema-copolymer and Etafilcon AGrade 025 participants
Etafilcon A LensLens Surface - Wettability - Hema-copolymer and Etafilcon AGrade 14 participants
Etafilcon A LensLens Surface - Wettability - Hema-copolymer and Etafilcon AGrade 21 participants
Etafilcon A LensLens Surface - Wettability - Hema-copolymer and Etafilcon AGrade 30 participants
Primary

Ocular Redness (Subjective Assessment) - Hema-copolymer and Etafilcon A

Subjective Assessment of ocular redness for hema-copolymer and etafilcon A lenses lenses assessed at 1 week. Scale 0-100, 0=extremely poor, 100= excellent.

Time frame: 1 week

Population: 11 subjects discontinued the study.

ArmMeasureValue (MEAN)Dispersion
Hema-copolymer LensOcular Redness (Subjective Assessment) - Hema-copolymer and Etafilcon A87.2 units on a scaleStandard Deviation 15.7
Etafilcon A LensOcular Redness (Subjective Assessment) - Hema-copolymer and Etafilcon A89.0 units on a scaleStandard Deviation 9
Primary

Overall Impression (Subjective Assessment) - Hema-copolymer and Etafilcon A

Subjective assessment of the overall impression for hema-copolymer and etafilcon A lenses assessed at 1 week. Scale 0-100, 0=extremely poor, 100= excellent.

Time frame: 1 week

Population: 11 subjects discontinued the study. Missing data of 1 subject for hema-copolymer group.

ArmMeasureValue (MEAN)Dispersion
Hema-copolymer LensOverall Impression (Subjective Assessment) - Hema-copolymer and Etafilcon A75.0 units on a scaleStandard Deviation 15.2
Etafilcon A LensOverall Impression (Subjective Assessment) - Hema-copolymer and Etafilcon A63.9 units on a scaleStandard Deviation 21.5
Primary

Overall Impression (Subjective Assessment) - Hema-copolymer and Etafilcon A

Subjective assessment of the overall impression for hema-copolymer and etafilcon A lenses assessed at baseline. Scale 0-100, 0=extremely poor, 100= excellent.

Time frame: Baseline

Population: 8 subjects discontinued the study.

ArmMeasureValue (MEAN)Dispersion
Hema-copolymer LensOverall Impression (Subjective Assessment) - Hema-copolymer and Etafilcon A81.3 units on a scaleStandard Deviation 14.6
Etafilcon A LensOverall Impression (Subjective Assessment) - Hema-copolymer and Etafilcon A78.9 units on a scaleStandard Deviation 14.5
Primary

Peripheral Blur (Subjective Assessment) - Hema-copolymer and Etafilcon A

Subjective Assessment of peripheral blur is assessed at baseline. Scale 0-100, 0=unacceptable, 100= excellent.

Time frame: Baseline

Population: 8 subjects discontinued the study.

ArmMeasureValue (MEAN)Dispersion
Hema-copolymer LensPeripheral Blur (Subjective Assessment) - Hema-copolymer and Etafilcon A85.1 units on a scaleStandard Deviation 14.7
Etafilcon A LensPeripheral Blur (Subjective Assessment) - Hema-copolymer and Etafilcon A87.6 units on a scaleStandard Deviation 14.9
Primary

Peripheral Blur (Subjective Assessment) - Hema-copolymer and Etafilcon A

Subjective Assessment of peripheral blur assessed at 1 week. Scale 0-100, 0=unacceptable, 100= excellent.

Time frame: 1 week

Population: 11 subjects discontinued the study.

ArmMeasureValue (MEAN)Dispersion
Hema-copolymer LensPeripheral Blur (Subjective Assessment) - Hema-copolymer and Etafilcon A80.2 units on a scaleStandard Deviation 16.4
Etafilcon A LensPeripheral Blur (Subjective Assessment) - Hema-copolymer and Etafilcon A76.4 units on a scaleStandard Deviation 17.3
Primary

Vision Preference (Subjective Assessment) - Hema-copolymer and Etafilcon A

Subjective Assessment of vision preference for hema-copolymer and etafilcon A lenses assessed at 1 week. Scale 0-100, 0=unacceptable, 100= excellent.

Time frame: 1 week

Population: 11 subjects discontinued the study.

ArmMeasureGroupValue (MEAN)Dispersion
Hema-copolymer LensVision Preference (Subjective Assessment) - Hema-copolymer and Etafilcon ADistance vision85.6 units on a scaleStandard Deviation 11.3
Hema-copolymer LensVision Preference (Subjective Assessment) - Hema-copolymer and Etafilcon AVision at night83.3 units on a scaleStandard Deviation 14
Hema-copolymer LensVision Preference (Subjective Assessment) - Hema-copolymer and Etafilcon AVariable vision83.1 units on a scaleStandard Deviation 17.4
Etafilcon A LensVision Preference (Subjective Assessment) - Hema-copolymer and Etafilcon ADistance vision71.6 units on a scaleStandard Deviation 22.7
Etafilcon A LensVision Preference (Subjective Assessment) - Hema-copolymer and Etafilcon AVision at night65.0 units on a scaleStandard Deviation 21.3
Etafilcon A LensVision Preference (Subjective Assessment) - Hema-copolymer and Etafilcon AVariable vision67.4 units on a scaleStandard Deviation 22.7
Primary

Vision Preference (Subjective Assessment) - Hema-copolymer and Etafilcon A

Subjective Assessment of vision preference for hema-copolymer and etafilcon A lenses assessed at baseline. Scale 0-100, 0=unacceptable, 100= excellent.

Time frame: Baseline

Population: 8 subjects discontinued the study.

ArmMeasureValue (MEAN)Dispersion
Hema-copolymer LensVision Preference (Subjective Assessment) - Hema-copolymer and Etafilcon A87.6 units on a scaleStandard Deviation 11.5
Etafilcon A LensVision Preference (Subjective Assessment) - Hema-copolymer and Etafilcon A84.4 units on a scaleStandard Deviation 12.3
Primary

Visual Acuity - Hema-copolymer and Etafilcon A

Visual acuity measured by logMAR for hema-copolymer and etafilcon A lenses assessed at 1 week.

Time frame: 1 week

Population: 11 subjects discontinued the study. Missing data of 1 subject for hema-copolymer group.

ArmMeasureGroupValue (MEAN)Dispersion
Hema-copolymer LensVisual Acuity - Hema-copolymer and Etafilcon AHigh Contrast-0.08 logMARStandard Deviation 0.1
Hema-copolymer LensVisual Acuity - Hema-copolymer and Etafilcon ALow Contrast0.18 logMARStandard Deviation 0.09
Etafilcon A LensVisual Acuity - Hema-copolymer and Etafilcon AHigh Contrast-0.04 logMARStandard Deviation 0.1
Etafilcon A LensVisual Acuity - Hema-copolymer and Etafilcon ALow Contrast0.23 logMARStandard Deviation 0.1
Primary

Visual Acuity - Hema-copolymer and Etafilcon A

Visual acuity measured by logMAR of hema-copolymer and etafilcon A lenses assessed at baseline.

Time frame: Baseline

Population: All 30 subjects were dispensed lenses, and visual acuity measurements were obtained at baseline.

ArmMeasureGroupValue (MEAN)Dispersion
Hema-copolymer LensVisual Acuity - Hema-copolymer and Etafilcon AHigh Contrast-0.08 logMARStandard Deviation 0.09
Hema-copolymer LensVisual Acuity - Hema-copolymer and Etafilcon ALow Contrast0.17 logMARStandard Deviation 0.1
Etafilcon A LensVisual Acuity - Hema-copolymer and Etafilcon AHigh Contrast-0.04 logMARStandard Deviation 0.09
Etafilcon A LensVisual Acuity - Hema-copolymer and Etafilcon ALow Contrast0.20 logMARStandard Deviation 0.14

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026